Discover the detailed record of transactions filed by Arnold Jonathan, Président, Livraison Orale et Spécialité. Director active across 1 companies, notably Catalent, Inc.. In total, 10 disclosures have been recorded. Total volume traded: €394k. The latest transaction was filed on 3 January 2022 — Attribution. Regulator: SEC (Form 4). The full history is accessible without signup.
Jonathan Arnold is the President of Oral & Specialty Delivery at Catalent, Inc. He oversees operations related to drug delivery and innovation in this area. His expertise contributes to product improvement and customer satisfaction. As a member of the management team, he plays a key role in the strategic direction of the organization.